Nanogenecs Diagnostics

📍 Cambridge, Canada🗓 Founded 2016👥 6 employees💰 Last funded Mar 2017
Nanogenecs is building a convenient and inexpensive medical diagnostic portable platform that measures your blood chemistry in a matter of minutes to deliver actionable insights. Such insights will improve the management of chronic diseases, bringing the safeguard high-quality laboratory testing at home. Our mission is to provide biomarker-based information to patients and healthcare professionals to promote preventive action, keeping people at home healthier and longer. Our team has expertise in molecular diagnostics, biosensors, clinical biochemistry, product design engineering, and the business aspects of translating disruptive science into world class products. Our proprietary nanotechnology is patent pending and brings a new class of lab quality sensors directly to the palm of your hand.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Nanogenecs Diagnostics?
Nanogenecs Diagnostics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Nanogenecs Diagnostics last raise funding?
The most recent investment in Nanogenecs Diagnostics recorded on gritt.io was in March 2017.
When was Nanogenecs Diagnostics founded?
Nanogenecs Diagnostics was founded in 2016.
What industry is Nanogenecs Diagnostics in?
Nanogenecs Diagnostics operates in Health, Wellness and Fitness. Find similar Health, Wellness and Fitness investors on gritt.io.
Where is Nanogenecs Diagnostics based?
Nanogenecs Diagnostics is headquartered in Cambridge, Canada.